参考文献/References:
[1] LEE R,WONG T Y,SABANAYAGAM C.Epidemiology of diabetic retinopathy,diabetic macular edema and related vision loss[J].Eye Vis(Lond),2015,2:17.
[2] 秦学维.基于iBRB与AQP4研究补肾活血法对早期糖尿病视网膜水肿的干预作用及其机制[D].成都:成都中医药大学,2018.
QIN X W.Study on effect and mechanism of Bushenhuoxue therapy on early diabetic retinal edema based on iBRB and AQP4[D].Chengdu:Chengdu University of Traditional Chinese Medicine,2018.
[3] 原公强.高浓度葡萄糖对培养的人视网膜微血管内皮细胞屏障功能的影响[D].青岛:青岛大学,2006.
YUAN G Q.Effects of high concentration of glucose on barrier function of cultured human retinal microvascular endothelial cells[D].Qingdao:Qingdao University,2006.
[4] 郭斌,惠延年,王应利.体外内层血视网膜屏障模型中Müller胶质细胞对紧密连接的影响[J].国际眼科杂志,2006,6(2):311-316.
GUO B,HUI Y N,WANG Y L.Effect of Müller glial cells on tight junction in the model of inner blood-retinal barrier in vitro[J].Int Eye Sci,2006,6(2):311-316.
[5] 马殿伟,谢学军,张梅,万李.补肾活血剂对TGF-β2干预缺氧状态下视网膜Müller细胞谷氨酸代谢的影响[J].眼科新进展,2013,33(9):804-807.
MA D W,XIE X J,ZHANG M,WAN L.Effects of Bushenhuoxue decoction on Glu metabolism in TGF-β2 -intervened retinal Müller cells under hypoxic condition[J].Rec Adv Ophthalmol,2013,33(9):804-807.
[6] 马殿伟,谢学军,张梅,万李.补肾活血剂对高糖和(或)缺氧状态下共同培养视网膜神经节细胞和Müller细胞谷氨酸代谢的影响[J].眼科新进展,2015,35(5):419-423.
MA D W,XIE X J,ZHANG M,WAN L.Effects of Bushenhuoxue decoction on glutamate metabolism in retinal ganglion cells and Müller cells co-cultured in high glucose concentration or(and) hypoxic conditions[J].Rec Adv Ophthalmol,2015,35(5):419-423.
[7] 马殿伟,谢学军,张梅,万李.补肾活血剂对高糖和(或)缺氧状态下视网膜神经节细胞活力及谷氨酰胺合成酶活性的影响[J].眼科新进展,2014,34(6):510-514.
MA D W,XIE X J,ZHANG M,WAN L.Effects of Bushenhuoxue decoction on activities of glutamine synthetase and RGC cultured in high glucose concentration or(and) hypoxic conditions[J].Rec Adv Ophthalmol,2014,34(6):510-514.
[8] 秦伟,谢学军,李志英,宋明霞,曹新伟,马殿伟,等.补肾活血方对AGEs条件下体外纯化培养大鼠视网膜Müller细胞HIF-1α介导缺氧信号通路的影响[J].中国中医眼科杂志,2017,27(2):71-75.
QIN W,XIE X J,LI Z Y,SONG M X,CAO X W,MA D W,et al.Study on influence of Bushen Huoxue decoction on signal pathway mediated by HIF-1α of RMCs cultured in AGEs condition[J].Chin J TCM Ophthalmol,2017,27(2):71-75.
[9] 杨培增,陈家祺,葛坚,吴德正.眼科学基础与临床[M].北京:人民卫生出版社,2006:800-806.
YANG P Z,CHEN J Q,GE J,WU D Z.Basic and clinical ophthalmology[M].Beijing:People’s Health Publishing House,2006:800-806.
[10] 李莹莹,蔺晓慧.多因素介导下糖尿病性视网膜病变的发生机制研究[J].医学综述,2018,24(24):4918-4921,4927.
LI Y Y,LIN X H.Study on the mechanism of diabetic retinopathy mediated by multiple factors[J].Med Rev,2018,24(24):4918-4921,4927.
[11] INADA M,TAGUCHI M,HARIMOTO K,KARASAWA Y,TAKEUCHI M,ITO M.Protective effects of dexamethasone on hypoxia-induced retinal edema in a mouse model[J].Exp Eye Res,2019,178:82-90.
[12] 杨敏.右归丸药物血清对体外高糖缺氧条件下大鼠视网膜微血管内皮细胞VEGF/PI3K/Akt信号通路的影响[D].兰州:甘肃中医药大学,2018.
YANG M.Effect of Yougui Pill Drug Serum on VEGF/PI3K/Akt signal pathway of rat retinal microvascular endothelial cells under high glucose and hypoxia in vitro[D].Lanzhou:Gansu University of Traditional Chinese Medicine,2018.
[13] CAMPBELL M,HUMPHRISE P.The blood-retina barrier:tight junctions and barrier modulation[J].Adv Exp Med Biol,2012,763:70-84.
[14] ROACH T,ALCENDOR D J.Zika virus infection of cellular components of the blood-retinal barriers:implications for viral associated congenital ocular disease[J].J Neuroinflammat,2017,14(1):43.
[15] LIU L,LIU X.Roles of drug transporters in blood-retinal barrier[J].Adv Exp Med Biol,2019,1141:467-504.
[16] TOUT S,CHAN-LING T,HOLLANDER H,STONE J.The role of Müller cells in the formation of the blood-retinal barrier[J].Neuroscience,1993,55(1):291-301.
[17] FRESTA C G,CARUSO G,FIDILIO A,PLATANIA C B M,MUSSO N,CARACI F,et al.Dihydrotanshinone,a natural diterpenoid,preserves blood-retinal barrier integrity via P2X7 Receptor[J].Int J Mol Sci,2020,21(23):9305.
[18] POENAR D P,YANG G,WAN W K,FENG S.Low-cost method and biochip for measuring the trans-epithelial electrical resistance(TEER) of esophageal epithelium[J].Materials (Basel),2020,13(10):2354.
[19] FU D,YU J Y,CONNELLl A R,HOOKHAM M B,MCLEESE R H,LYONS T J.Effects of modified low-density lipoproteins and fenofibrate on an outer blood-retina barrier model:implications for diabetic retinopathy[J].J Ocul Pharmacol Ther,2020,36(10):754-764.
[20] 李璐.补阳还五汤及其拆方对血脑屏障通透性的体外研究[D].郑州:河南中医学院,2017.
LI L.In vitro study of Buyang Huanwu decoction and its disassembled prescriptions on the permeability of blood-brain barrier[D].Zhengzhou:Henan College of Traditional Chinese Medicine,2017.
[21] CONG X,KONG W.Endothelial tight junctions and their regulatory signaling pathways in vascular homeostasis and disease[J].Cell Signal,2020,66:109485.
[22] HEINEMANN U,SCHUETZ A.Structural features of tight-junction proteins[J].Int J Mol Sci,2019,20(23):6020.
[23] WANG F,WANG D,SONG M,ZHOU Q,LIAO R,WANG Y.MiRNA-155-5p reduces corneal epithelial permeability by remodeling epithelial tight junctions during corneal wound healing[J].Curr Eye Res,2020,45(8):904-913.
[24] SUN R,GE L,CAO Y,WU W,WU Y,ZHE H,et al.MiR-429 regulates blood-spinal cord barrier permeability by targeting Krüppel-like factor 6[J].Biochem Biophys Res Commun,2020,525(3):740-746.
[25] 程岩.Robo4在调节血管内皮细胞通透性中的主要及机制研究[D].长春:吉林大学,2013.
CHENG Y.Study on the main and mechanism of Robo4 in regulating vascular endothelial cell permeability[D].Changchun:Jilin University,2013.